logo
#

Latest news with #EquityIncentivePlan

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Globe and Mail

time2 days ago

  • Business
  • Globe and Mail

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANN ARBOR, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on August 5, 2025, the Company granted 12 new employees 73,500 restricted stock units (RSUs) under Esperion's 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Esperion, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. Each RSU will vest and become exercisable as to 25 percent of the shares on the one-year anniversary of the recipient's vesting commencement date and will vest and become exercisable as to the remaining 75 percent of the shares in twelve equal quarterly installments at the end of each quarter following such anniversary, in each case, subject to each such employee's continued employment with Esperion on such vesting dates. The RSUs are subject to the terms and conditions of Esperion's 2017 Inducement Equity Incentive Plan, and the terms and conditions of the RSU agreement covering the grant. Esperion Therapeutics Esperion Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on bringing new medicines to market that address unmet needs of patients and healthcare professionals. The Company developed and is commercializing the only U.S. Food and Drug Administration (FDA) approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease and are struggling with elevated low density lipoprotein cholesterol (LDL-C). These medications are supported by the nearly 14,000 patient CLEAR Cardiovascular Outcomes Trial. Esperion continues to build on its success with its next generation program which is focused on developing ATP citrate lyase inhibitors (ACLYi). New insights into the structure and function of ACLYi fully enables rational drug design and the opportunity to develop highly potent and specific inhibitors with allosteric mechanisms. Esperion continues to evolve into a leading global biopharmaceutical company through commercial execution, international partnerships and collaborations and advancement of its pre-clinical pipeline. For more information, visit and follow Esperion on LinkedIn and X.

Tesla committee approves award of 96M shares of restricted stock to CEO Musk
Tesla committee approves award of 96M shares of restricted stock to CEO Musk

Business Insider

time5 days ago

  • Automotive
  • Business Insider

Tesla committee approves award of 96M shares of restricted stock to CEO Musk

In a regulatory filing, Tesla (TSLA) stated: 'As previously disclosed in its quarterly report on Form 10-Q for the three months ended March 31, 2025, the board of directors of Tesla, Inc., a Texas corporation, established a special committee to consider certain compensation matters involving Elon Musk, the Company's Chief Executive Officer. The Special Committee is comprised of disinterested directors Robyn Denholm and Kathleen Wilson-Thompson. On August 3, 2025, the company approved an award of 96 million shares of restricted stock to Mr. Musk under the Company's 2019 Equity Incentive Plan. The shares underlying the 2025 CEO Interim Award will be issued upon termination or expiration of the waiting period or periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. The 2025 CEO Interim Award was recommended by the Special Committee on August 1, 2025, and approved by the Board, with Mr. Musk and Kimbal Musk recusing, on August 3.' Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

COMMERCE RESOURCES AND MONT ROYAL RESOURCES ANNOUNCE ISSUE OF INCENTIVE OPTIONS AND PERFORMANCE SHARE UNITS
COMMERCE RESOURCES AND MONT ROYAL RESOURCES ANNOUNCE ISSUE OF INCENTIVE OPTIONS AND PERFORMANCE SHARE UNITS

Cision Canada

time28-07-2025

  • Business
  • Cision Canada

COMMERCE RESOURCES AND MONT ROYAL RESOURCES ANNOUNCE ISSUE OF INCENTIVE OPTIONS AND PERFORMANCE SHARE UNITS

MONTREAL, July 28, 2025 /CNW/ -- Commerce Resources Corp. ("Commerce" or the "Company") (TSXV: CCE, FSE: D7H0) is pleased to announce that it has granted (the "Grant") an aggregate of 3,000,000 incentive stock options (each, an "Option") to purchase up to 3,000,000 common shares of the Company (each, a "Share") equally to Nicholas Holthouse, Jeremy Robinson and Adam Ritchie under its Equity Incentive Plan. The Options are exercisable for a period of three years from the date of Grant, expiring on July 28, 2028, at a price of $0.139 per Share. The options all vest immediately. Further, the Company has issued 15,000,000 Performance Share Units (PSU) to convert up to 15,000,000 Shares to certain officers under its Equity Incentive Plan. 9,000,000 PSU's to be issued to CEO and President Nicholas Holthouse and a further 3,000,000 to be issued to Jeremy Robinson and Adam Ritchie respectively. The PSU's will expire on 12 July 2028 for Mr Holthouse and 28 July 2028 for Mr Robinson and Mr Ritchie. For more information, please visit the corporate website at or email [email protected]. On Behalf of the Board of Directors COMMERCE RESOURCES CORP. Ian Graham Chairman Tel: 604.484.2700 Email: [email protected] Web: Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains forward-looking statements, which includes any information about activities, events or developments that the Company believes, expects or anticipates will or may occur in the future. Forward looking statements in this news release include statements regarding the proposed Transaction and the terms thereof; the anticipated filing of materials on SEDAR+; the completion of the Transaction, including, receipt of all necessary court, shareholder and regulatory approvals and timing thereof; the proposed Consolidation and the terms thereof; the expectation that the Commerce Shares will be delisted from the TSXV; the expectation that the Mont Royal Shares will be dual-listed on the ASX and TSXV; the continued advancement of the Ashram Project to development; that Ashram's fluorspar component which makes it one of the largest potential sources of fluorspar in the world and could be a long-term supplier to the met-spar and acid-spar markets; that the Company is positioning to be one of the lowest cost rare earth element producers globally, with a focus on being a long-term global supplier of mixed rare earth carbonate and/or NdPr oxide; and that the Company may explore the potential of other high-value commodities on the Ashram Property. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Risks that could change or prevent these events, activities or developments from coming to fruition include: the ability to obtain approvals in respect of the Transaction and to consummate the Transaction, the ability to obtain approvals for the listing of the Mont Royal Shares on the TSXV and the ASX; integration risks, actual results of current and future exploration activities; that the Company may not be able to fully finance any additional exploration on the Ashram Project; that even if the Company is able raise capital, costs for exploration activities may increase such that the Company may not have sufficient funds to pay for such exploration or processing activities; the timing and content of the proposed drill program and any future work programs may not be completed as proposed or at all; geological interpretations based on drilling that may change with more detailed information; potential process methods and mineral recoveries assumptions based on limited test work and by comparison to what are considered analogous deposits that, with further test work, may not be comparable; testing of our process may not prove successful or samples derived from the Ashram Project may not yield positive results, and even if such tests are successful or initial sample results are positive, the economic and other outcomes may not be as expected; the anticipated market demand for rare earth elements and other minerals may not be as expected; the availability of labour and equipment to undertake future exploration work and testing activities; geopolitical risks which may result in market and economic instability; and despite the current expected viability of the Ashram Project, conditions changing such that even if metals or minerals are discovered on the Ashram Project, the project may not be commercially viable, or other risks detailed herein and from time to time in the filings made by the Company with applicable Canadian securities regulators. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ from those described in forward-looking statements, there may be other factors that cause such actions, events or results to differ materially from those anticipated. These forward-looking statements are based on our current expectations, estimates, forecasts and projections about our business and the industry in which we operate and management's beliefs and assumptions, including the non-occurrence of the risks and uncertainties that are described above and in the filings made with the applicable Canadian securities regulators or other events occurring outside of our normal course of business, and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

Cygnus Metals Limited: Issue of Performance Rights
Cygnus Metals Limited: Issue of Performance Rights

Yahoo

time11-07-2025

  • Business
  • Yahoo

Cygnus Metals Limited: Issue of Performance Rights

TORONTO, July 11, 2025 (GLOBE NEWSWIRE) -- Cygnus Metals Limited ('Cygnus' or the 'Company') advises that it has issued an aggregate of 67,050,000 performance rights ('Performance Rights') to directors, and key employees and consultants, under the Company's Omnibus Equity Incentive Plan ('Plan'). Shareholders approved the Plan and the issue of Performance Rights to directors at the Company's annual general meeting held on May 14, 2025. The Performance Rights to key personnel were issued on the same terms and conditions as the director Performance Rights, as set out in the notice of annual general meeting released to ASX on April 14, 2025. The Performance Rights vest on the later of (a) one year after their date of issue, and (b) the successful completion of specific key performance objectives within three years from the date of issue. Each vested Performance Right is exercisable to one fully paid ordinary share in the capital of the Company (net of applicable withholdings) and will expire on May 31, 2030 unless exercised on or before this date. The objective of Cygnus' Plan is to promote the long-term success of the Company and the creation of shareholder value by aligning the interests of eligible persons under the Plan with the interests of the Company. This announcement has been authorised for release by the Board of Directors of Cygnus. David SouthamExecutive ChairT: +61 8 6118 1627E: info@ Ernest MastPresident & Managing DirectorT: +1 647 921 0501E: info@ Media:Paul Armstrong Read Corporate +61 8 9388 1474 About Cygnus Metals Cygnus Metals Limited (ASX: CY5, TSXV: CYG) is a diversified critical minerals exploration and development company with projects in Quebec, Canada and Western Australia. The Company is dedicated to advancing its Chibougamau Copper-Gold Project in Quebec with an aggressive exploration program to drive resource growth and develop a hub-and-spoke operation model with its centralised processing facility. In addition, Cygnus has quality lithium assets with significant exploration upside in the world-class James Bay district in Quebec, and REE and base metal projects in Western Australia. The Cygnus team has a proven track record of turning exploration success into production enterprises and creating shareholder in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Base Carbon Announces Shareholder Meeting Results
Base Carbon Announces Shareholder Meeting Results

Yahoo

time25-06-2025

  • Business
  • Yahoo

Base Carbon Announces Shareholder Meeting Results

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates, 'Base Carbon', or the 'Company'), is pleased to announce the results of its Shareholder Meeting (the 'Meeting'). A total of 57,044,319 common shares, representing 52.60% of the issued and outstanding common shares of the Company, were represented at the Meeting. Six (6) directors were elected to the Company's board for the ensuing year. The following is a tabulation of the votes submitted in person and by proxy: Director Nominee # of Votes in Favour % of Votes in Favour # of Votes Withheld % of Votes Withheld Catherine Flax 55,679,343 97.761% 1,274,976 2.239% Margot Naudie 53,811,527 94.842% 2,926,814 5.158% Bruce Tozer 55,639,843 97.538% 1,404,476 2.462% Michael Costa 56,809,366 99.588% 234,953 0.412% Andrew Fedak 56,788,673 99.552% 255,646 0.448% Adrian Morante 56,809,366 99.588% 234,953 0.412% Shareholders also voted in favor of an ordinary resolution to approve, ratify and confirm the amended and restated equity incentive plan (the 'Equity Incentive Plan') and the unallocated shares underlying awards under the Equity Incentive Plan, the full text of which is set out in the information circular prepared for the Meeting. # of Votes in Favour % of Votes in Favour # of Votes Against % of Votes Against 53,389,021 93.592% 3,655,298 6.408% For more information refer to the management information circular dated May 15, 2025, available on the Company's profile at About Base Carbon Base Carbon is a financier of projects involved primarily in the global voluntary carbon markets. We endeavor to be the preferred carbon project partner in providing capital and management resources to carbon removal and abatement projects globally and, where appropriate, will utilize technologies within the evolving environmental industries to enhance efficiencies, commercial credibility, and trading transparency. For more information, please visit Media and Investor Inquiries Base Carbon RelationsTel: +1 647 952 3979E-mail: investorrelations@ Media InquiriesE-mail: media@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store